STUDY QUESTION: Is there a specific mechanism to load the microRNA (miRNA), hsa-miR-30d, into exosomes to facilitate maternal communication with preimplantation embryos?
Introduction
Currently, microRNAs (miRNAs) constitute a promising model for cell-to-cell communication (Valadi et al., 2007) since they are transferred between cells to execute essential roles in many processes. Their structure and size, in addition to various transport mechanisms, allow them to remain stable within various biological fluids (Turchinovich et al., 2013; Larrea et al., 2016) , surviving in extremely adverse conditions, including low pH, boiling and freezing (Pieters et al., 2015) . The presence of miRNAs in reproductive fluids, such as follicular, uterine and seminal fluid, indicate potential roles in the reproductive system. These extracellular miRNAs can be transported by lipoproteins [both high-density lipoprotein (HDL) and low-density lipoprotein (LDL)] Vickers et al., 2011; Michell and Vickers, 2016 or other proteins, including Argonaute2 (AGO2; Arroyo et al., 2011; Turchinovich et al., 2011) and nucleophosmin1 (NPM1; Wang et al., 2010) . Another transport system is mediated by extracellular vesicles (EVs), such as apoptotic bodies (Zernecke et al., 2009) , microvesicles (MVs) (Hunter et al., 2008) and/or exosome-like vesicles (Harding et al., 2013) . EVs protect miRNAs from degradation and contribute to their stability within biological fluids (Pieters et al., 2015) . Furthermore, EVs can transport a wide range of components packaged in a selective way. For instance, Squadrito et al. (2014) , used macrophages and endothelial cells to demonstrate that the sorting of miRNAs into EVs for heterotrophic cell communication is altered by both, the presence of target transcripts and presence of the miRNAs themselves (Squadrito et al., 2014) . In addition, the repertoire of miRNAs found in the exosomes significantly differs for that in the parent cells (KoppersLalic et al., 2014) .
To date, mechanisms controlling the specific loading of miRNAs into exosomes remain unclear. Indeed, several mechanisms may govern exosome sorting of specific subsets of miRNAs (Santangelo et al., 2016) . miRNA sorting appears to be influenced by different pathways and molecules in different cell types and tissues (VillarroyaBeltri et al., 2013; Janas et al., 2015; Zhang et al., 2015) , and miRNAs contain well-defined motifs (i.e. EXOmotifs), that direct the miRNA allocation into exosomes before delivery into recipient cells (Villarroya-Beltri et al., 2013) . A recent study showed that this RNA sequence can be recognized by the sumoylated form of the heterogeneous ribonucleoprotein A2B1 (hnRNPA2B1; Villarroya-Beltri et al., 2013) . Moreover, a terminal 30 nucleotide addition in miRNAs affects their selective sorting in B cells (Koppers-Lalic et al., 2014) . Another hypothesis suggests that RNAs are selectively sorted depending on the differential affinity of RNA motifs towards the raft-like region of the cytoplasmic surface of multivesicular body (MVB) limiting membranes (Janas et al., 2015) .
Current data indicate that cells can communicate with each other through the transfer of miRNA-loaded exosomes Mittelbrunn et al., 2011; Hergenreider et al., 2012; Montecalvo et al., 2012; Roccaro et al., 2013) . For example, monocyte-derived exosomes deliver miR-150 to endothelial cells and enhance endothelial cell migration by reducing c-myb expression . The miRNA content of exosomes plays a critical role in such cell-to-cell communication and determines the fate of recipient cells. Thus, exosomes derived from the bone marrow mesenchymal stromal cells of myeloma patients promote tumor growth depending on the content of miR-15a in exosomes (Roccaro et al., 2013) .
Our group has described a novel cell-to-cell communication mechanism involving the delivery of endometrial miRNAs from the maternal endometrium to the trophectoderm cells of preimplantation embryos (Vilella et al., 2015) . Specifically, in B6C3 derived mouse embryos, we found EV-associated and free miR-30d to cause overexpression of genes involved in embryonic adhesion processes, including Itb3, Itga7 and Cdh5 (Vilella et al., 2015) . Furthermore, supplementing murine embryos with miR-30d significantly improved embryo adhesion, suggesting that external miRNAs may have a functional role as transcriptomic modifiers of preimplantation embryos. Based on profiling of miRNAs in endometrial fluid, maternally-derived miRNAs are present within EVs in the uterine microenvironment. The internalization of maternally-derived exosomes has been visualized, but the mechanism by which miR-30d becomes incorporated into exosomes remains unknown. The present study aimed to elucidate the underlying mechanism of hsa-miR-30d transfer from human endometrial epithelial cells (hEECs) to the interior of exosomes and eventually to early-stage blastocysts, using a mir-30d knockout (KO) murine model.
Materials and Methods

Recovery of preimplantation mouse embryos
Mice lacking miR-30d and their wild-type (WT) counterparts, were obtained from Jackson laboratories from the strain MirC26tm1Mtm/ Mmjax using as background C57BL/6, Fvb and 192P2. Adult mice were caged in a controlled environment with a cycle of 14L:10D. All animal procedures were approved by the Ethics Commission in Experimental Research of the University of Valencia authorized by the Department of Agriculture, Livestock and Fisheries of the Spanish Government (Code: 2015/VSC/PEA/00048). Female mice, aged 6-8 weeks, were primed to ovulate by administering 10 IU of pregnant mare serum gonadotropin (Sigma-Aldrich, Madrid, Spain). Forty-eight hours later, 10 IU of hCG (Sigma-Aldrich) were administrated. Females were housed overnight with male studs and examined the following morning for the presence of a vaginal plug (classified as Day 1 of pregnancy). On day E1.5 of pregnancy, the mice were euthanized by cervical dislocation and embryos flushed from the oviduct with PBS (Life Technologies, Waltham, MA, USA) using a 30-gauge blunt needle. Embryos were then washed four times in fresh CCM-30 medium (Vitrolife, Englewood, CO, USA). After washing was completed, embryos were incubated at 37°C, 5% CO 2 in air in CCM-30 medium for 72 h until they arrived at a hatching stage.
Detection of miR-30d using confocal microscopy WT or KO embryos at day E4.5 were co-cultured in μ-Slide 8-Well ibiTreat plates (Ibidi Gmbh, Planegg/Martinsried, Germany) on hEECs previously transfected with Molecular Beacon (MB) probes (200 ng/μl) specifically customized to recognize miR-30d in vivo. The design of the miR-30d MB was performed by Dharmacon (Lafayette, CO, USA). MBs are internally quenched hairpin-shaped oligonucleotide probes that fluoresce upon hybridization with their target sequence. Target-bound probes fluoresce as much as 100 times more intensely than background levels of unbound probes, enabling highly sensitive detection. Due to their stem, the recognition of targets by an MB is so specific that if the target differs even by a single nucleotide, the probe will not bind (Bratu et al., 2011) . Sequences of the MB targeting miR-30d and the one used as a negative control are: (miR-30d)-5′-CAC UGC AGU CGG CGA UGU UUA CCA GUG-3 and (negative control)-5′-CUC AGA AAA AAA AAA AAA AAA AAC UGA C. The transfection was performed using HiPerfect (Qiagen, Hilden, Germany) transfection reagent following manufacturer's instructions. After 6 h of treatment, the medium was replaced. Twenty-four hours after transfection, fluorescence could be observed. For visual inspection of the uptake of miR-30d by mouse embryos, the cell embryo co-culture was incubated at 37°C, under 5% CO 2 in air for 30 min with 5 μg/ml of Hoechst 33342 (Sigma-Aldrich, Madrid, Spain) and 10 μg/ml of WGAAlexa 488 (Life Technologies, Molecular Probes, Eugene, OR, USA), for nuclear and membrane staining, respectively. Once the labeling was completed, samples were visualized at 60× with a water immersion confocal microscope (FV1000, Olympus). 3D modeling and live animations were carried out using Imaris software. Quantification of intensity fluorescence was performed with ImageJ software. Experiments were performed in triplicate, so that in each replicate, the signal distribution of 3-4 embryos, per condition tested, was analyzed. In the results, a representative experiment is shown.
Thermal denaturation profiles of the MB
Thermal denaturation profiles were used to determine the specificity of the molecular beacon probe used in this study. The changes in fluorescence of a 10-μl solution containing 0.2 μM of the beacon probe with [miR-30d mimic: 5′-UGUAAACAUCCCCGACUGGAAG; Ref: MSY0000245; Qiagen, Hilden, Germany] or without 1 μM of a complementary single-stranded oligonucleotide were measured. Solutions were analyzed in Quantum Studio 5 Real-time PCR system. Specifically, samples were initially heated to 95°C and held at this temperature for 10 min; then, they were gradually cooled to 25°C at a rate of 1.6°C/s. As a negative control, the miRNA, miR-190 was used (miR-190 mimic: 5′-UGAUAUGUUUGAUAUAUUAGGU; Ref: MS00008911).
Detection of miR-30d using transmission electron microscopy WT and KO embryos at day E4.5 were co-cultured in μ-Slide 8-Well ibiTreat plates (Ibidi Gmbh, Planegg/Martinsried, Germany) with hEEC cells that were previously transfected with Smartflare probes (Millipore, Burlington, MA, USA). Confluent hEECs were incubated for 20 h with 8 μl of a work solution comprised of a Smartflare probe (miR-30d probe or Scramble control) at a 1:20 dilution in PBS. Smartflare probes comprise a gold nanoparticle conjugated with many copies of the same doublestranded oligonucleotide encoding the target sequence. After 24 h of co-culture, samples were processed to identify the location of the gold nanoparticles within epithelial and trophectoderm cells. For this, the co-culture was fixed with Karnovsky's solution for 1 h; and then a postfixation process in osmium tetroxide was performed. Next, several washes were done prior to staining with uranyl acetate. Samples were dehydrated, embedded in epoxy resin, ultrasectioned, transferred to carbon-coated grids, and observed using a JEM-1010 transmission electron microscope (Jeol Korea Ltd) at 100 000 kV.
hEEC primary cultures and exosome isolation
Endometrial biopsies were obtained at day LH+0 from healthy 18-35-year-old donors. Patients diagnosed with endometriosis and/or endometritis were excluded. All patients signed informed consent prior to the sample collection; procedures were approved by the local Ethical Committee at IVI Valencia, Spain (code:1308-FIVI-127-FV). Endometrial samples were processed to separate the epithelial and stromal fractions by collagenase digestion and gravity sedimentation as previously described (Simón et al., 1997) . When cultures reached confluence, they were washed with DMEM (SigmaAldrich, Madrid, Spain) to remove FBS-contaminated exosomes and then cultured in serum-depleted hEEC medium. After 24 h, the conditioned medium was collected, and cells were incubated again with hEEC medium without serum for 24 h. All collected conditioned media was subjected to a series of differential centrifugations: (1) media were centrifuged at 300g for 10 min to pellet residual cells; (2) next, supernatants were centrifuged at 2000g for 10 min; (3) the supernatants from step 2 were centrifuged at 10 000g for 30 min; (4) the supernatants from step 3 were passed through 0.22-μm diameter filters (Acrodisc ® syringe filters, Pall Corporation, Newquay Cornwall, UK) and centrifuged at 120 000g for 70 min using a P50AT4 Hitachi rotor.
Step 4 supernatants were kept as extracellular vesicles (EV)-negative controls for further analysis.
Step 4 pellets were resuspended in 1 ml PBS and centrifuged again under the same conditions (120 000g, 70 min). The pellet obtained contained the exosome enriched fraction.
miRNA pull-down 
Protein identification by mass spectroscopy
In-gel digestion of proteins Samples were digested with sequencing grade trypsin (500 ng; Promega, Madison, WI, USA) as described elsewhere (Shevchenko et al., 1996) . Briefly, each slide was cut and small pieces of~1 mm 2 in size were transferred into 1.5 ml Eppendorf tubes. After washing in 50 mM ammonium bicarbonate (ABC) in water pH 8 (Sigma-Aldrich, Madrid, Spain) the gel was dehydrated in acetonitrile (ACN; Fisher Scientific, Waltham, MA, USA), reduced with dithiothreitol (DTT; 10 mM in 50 mM ABC; 20 min at 60°C) and alkylated with iodoacetamide (IAM; 50 mM in 50 mM ABC; 30 min RT in the dark). For protein digestion, 500 ng of trypsin in 200 μl of 50 mM ABC was added to each dried gel piece and digestion was done at 37°C overnight. The trypsin digestion was stopped by adding 10% trifluoroacetic acid (TFA) to 1% final concentration, and the supernatant, containing the extracted digests, was carefully removed, leaving behind the sliced gels in the Eppendorf tube. Then, for additional peptide extraction, 200 μl of pure ACN, were added to each tube and incubated for 15 min at 37°C in a shaker. The new supernatant containing the new peptide mixture was carefully withdrawn. Both supernatants were mixed in a tube and dried in a speed vacuum (ISS 110 SpeedVac System, Thermo Savant, ThermoScientific, Langenselbold, Germany) for 20 min and re-suspended in 15 μl of 2% ACN and 0.1% TFA prior to LC and MS analysis.
Nano-liquid chromatography tandem-mass spectrometry analysis
The peptides recovered from in-gel digestion processing were analyzed by liquid chromatography (LC) using a NanoLC Ultra 1-D plus Eksigent ® (Eksigent Technologies, Dublin, CA, USA) which was directly connected to an SCIEX TripleTOF 5600 mass spectrometer (SCIEX, Framingham, MA, USA) in direct injection mode. Briefly, 5 μl from each digested sample was trapped on a NanoLC precolumn (3 μm particles size C18-CL, 350 μm diameter x 0.5 mm long; Eksigent) and desalted with 0.1% TFA at 3 μl/min during 5 min. Then, the digested peptides present in the samples were separated using an analytical LC column (3 μm particles size C18-CL, 75 μm diameter × 12 cm long, Nikkyo Technos Co ® , Tokyo, Japan) equilibrated in 5% ACN 0.1% formic acid (FA; Fisher Scientific, Waltham, MA, USA). The peptides were eluted from the column with a linear gradient from 5-40% of solvent B at a constant flow rate of 300 nl/min over 120 min. Solvent A being 0.1% FA in water and solvent B being 0.1% FA in ACN. Eluted peptides were ionized applying 2.8 kV to the spray emitter on an ESI Nanospray III (SCIEX). Analysis was carried out in a data-dependent mode. Survey MS1 scans were acquired from 350 to 1250 m/z for 250 ms. The quadrupole resolution was set to 'UNIT' for MS2 experiments, which were acquired 100-1500 m/z for 50 ms in 'high sensitivity' mode. Following dynamic selection criteria were used: charge: 2+ to 5+; minimum intensity; 70 counts per second (cps). Up to 50 ions were selected for fragmentation after each survey scan. Dynamic exclusion time was set to 15 s. Collision energy was automatically set by the instrument according to its Rolling collision energy equations.
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE (Vizcaíno et al., 2016) partner repository, with the dataset identifier PXD008773 and 10.6019/ PXD008773.
Protein identification
The MS/MS information was sent to PARAGON algorithm via the software ProteinPilot v 4.5 (ABSciex). ProteinPilot default parameters were used to generate peak list directly from 5600 TripleTof. The Paragon algorithm of ProteinPilot was used to search Expasy protein database with the following parameters: trypsin specificity, cys-alkylation, no taxonomy restriction and the search effort set to through. To avoid using the same spectral evidence for more than one protein, the identified proteins were grouped based on MS/MS spectra by the ProteinPilot Progroup algorithm. A protein group in a Pro Group Report is a set of proteins that share some spectral evidence. Then, unobserved regions of protein sequence play no role in explaining the data. The False Discovery Rate (FDR) analysis was performed with the PSPEP algorithm implemented in ProteinPilot (see Supplementary files 1-6).
Endometrial epithelial cell lysates
hEECs used for exosome collection served as positive controls for western blot analysis. To obtain cellular lysates, cells were washed with PBS and frozen at −80°C for at least 1 h. Then, they were incubated with 1.5 ml of RIPA buffer (150 mM NaCl, 1% IGEPAL CA 630, 0.5% Na-DOC, 0.1% SDS, 0.5 M EDTA, 50 mM Tris-HCl, pH 8) with protease inhibitors [1% PMSF 0.1 M (Sigma-Aldrich, Madrid, Spain), 10% Roche mini complete (Roche, Basel, Switzerland)] for 10-15 min. Once lysis was complete, the supernatant was centrifuged for 13 000g for 15 min. The pellet obtained was discarded and the resulting supernatant frozen until use. Quantification of proteins was performed by BCA protein assay kit (Pierce, Rockford, IL, USA).
Western blot
Antibodies against human CD63, CD9, CD81, HSP70 (System Biosciences, Palo Alto, CA, USA), actin (ab8227, Abcam, Cambridge, UK), CYR61 (ab24448, Abcam, Cambridge, UK), hnRNPC1 (ab10294, Abcam, Cambridge, UK) and calnexin (Enzo Life Sciences, Farmingdale, NY, USA) were used for western blotting. Isolated exosomes secreted from primary hEECs cultures were lysed in RIPA buffer at 4°C for 20 min. Samples were quantified using a BCA protein assay kit (Pierce, Rockford, IL, USA) and analyzed by SDS-PAGE, followed by electroblotting onto PVDF membranes (Bio-Rad Laboratories, Hercules, CA, USA). Membranes were incubated overnight with specific primary (1:1000) antibodies diluted in 3% skimmed milk, following the specifications of the manufacturers. After three washes with 1% PBST, membranes were incubated with a 1:20 000 dilution of secondary antibodies (Santa Cruz Biotechnology, Dallas, TX, USA). Finally, target proteins were detected by using the SuperSignal West Femto Chemiluminiscent kit (Thermo Fisher Scientific, Waltham, MA, USA). Western blots of the whole lysates and exosomes were performed in triplicate, a representative image is shown.
Subcellular fractionation
hEEC subcellular compartments were fractionated with the Subcellular Proteome Extraction kit (Calbiochem, Burlington, MA, USA). Cytosol, membranous organelles, and nuclear fractions were blotted for hnRNPC1 (ab10294, Abcam, Cambridge, UK), the cytosolic marker HSP70 (System biosciences, Palo Alto, CA, USA), the tetraspanin markers CD81, CD63 and CD9 (System biosciences, Palo Alto, CA, USA), the membrane organelle marker Calnexin (Enzo Life Sciences, Farmingdale, NY, USA), the nuclear marker Histone 4 (ab10158, Abcam, Cambridge, UK) and the cytoskeletal marker Actin (ab8227, Abcam, Cambridge, UK). Western blots of the subcellular fractions were performed twice. A representative image is shown. ) for 10 min at RT. Blocking was done with 4% normal goat serum for 30 min at RT. Incubation with a 1:50 dilution of primary antibodies against hnRNPC1 (ab10294, Abcam, Cambridge, UK) and CYR61 (ab24448, Abcam, Cambridge, UK) was performed o/n following the manufacturers' instructions. Cells were washed three times before a 60-min incubation with secondary antibodies. Alexa 488 and Alexa 555 labeled antibodies (5 μg/ml) (Life technologies, Molecular Probes, Eugene, OR, USA) were used to identify the proteins of interest and the exosome marker CD63. The labeled cells were washed three times and protein co-localization visualized with a 60× water immersion confocal microscope (FV1000, Olympus). Images were processed and assembled using Imaris software. Co-localization studies were performed in triplicate, representative images are presented. For within-cell immunofluorescence analysis of hnRNPC1, plates (Nunc 146485 24-well plates, Waltham, MA, USA) intended for In-Cell analysis (In-Cell Analyzer 2000) were used. In-Cell analysis was performed in triplicate.
Flow cytometry analysis of exosome-coupled beads
Exosomes were obtained using ultracentrifugation, resuspended in PBS and coupled to 4 mm aldehyde-sulfate beads (Invitrogen, Carlsbad, CA, USA) overnight at RT with rotation. Beads were washed and blocked for 60 min at RT in 4% bovine serum albumin in PBS. For intracellular staining, bead-bound exosomes were permeabilized and fixed for 5 min at RT with 0.2% Triton X-100, 2% formaldehyde in PBS. Beads were incubated with anti-hnRNPC1 (Abcam, Cambridge, UK) or anti-CD9 (System biosciences, Palo Alto, CA, USA) for 1 h at 4°C, washed and incubated with Alexa 488-goat-anti-mouse IgG (Invitrogen, Carlsbad, CA, USA) for 30 min. Bead signals were acquired on a FACSCalibur (BD Biosciences, USA) and data were analyzed with FlowJo software (Tree Star). Negative controls were obtained with exosome-coupled beads incubated with the secondary antibody. FACS was performed twice, a representative experiment is presented.
Validation of the miRNA pull-down assay
Sample preparation
The Ishikawa endometrial carcinoma cell line purchased from SigmaAldrich (Ref: 99040201) was used to validate the results obtained from the miRNA pull-down assay. Cells were grown in T-175 flask until reaching confluence, using the following culture media: MEM (Sigma-Aldrich, Madrid, Spain), 2 mM glutamine, 1% non-essential amino acids (NEAA), 5% FBS, 0.2% gentamycin and 0.2% fungizone. Next, they were washed with DMEM (Sigma-Aldrich, Madrid, Spain) to remove FBS-contaminated exosomes and then cultured in serum-depleted medium. After 24 h, the conditioned medium was collected in order to isolate the exosomes as described. A pool of the media from five flask T-175 was used to obtain the exosomes. Once the isolation was finished, exosomes were lysed in the following buffer (25 mM Tris pH 8, 150 mM NaCl, 2 mM MgCl2, 0.5% NP-40, 5 mM DTT, protease inhibitors and 40 U/ml RNAse inhibitor (Invitrogen)). Regarding the cell lysate, this was collected in the same way as the hEEC extract was obtained.
Immunoprecipitation
Protein G Dynabeads (50 μl per condition) (Invitrogen, Carlsbad, CA, USA) were washed twice in buffer 3 (PBS, 0.01% Tween) and resuspended in 200 μl of buffer 3 containing 10 μg mouse anti-hnRNPA2B1 (Santa Cruz Biotechnology, Dallas, TX, USA) or mouse anti-IgG control (Santa Cruz Biotechnology, Dallas, TX, USA) and incubated overnight at 4°C. Isolated exosomes and cell lysates were incubated (1 h, 4°C) with non-conjugated Dynabeads (50 μl per condition). The precleared lysates were incubated with 50 μl of Ab-conjugated Dynabeads (1.5 h, 4°C), which were then washed twice with buffer 4 (25 mM Tris pH 8, 150 mM NaCl, 2 mM MgCl2, 0.5%NP-40, 5 mM DTT), protease inhibitors and 40 U/ml RNAse inhibitor (Invitrogen, Carlsbad, CA, USA) and three times with buffer 5 (25 mM Tris pH 8, 900 mM NaCl, 2 mM MgCl2, 1%NP-40, 5 mM DTT, protease inhibitors and 40 U/ml RNAse inhibitor). Next, they were transferred to clean tubes and washed with buffer 6 (25 mM Tris pH 8, 150 mM NaCl, 2 mM MgCl2, 0.05% NP-40, 5 mM DTT; protease inhibitors and 40 U/ml RNase inhibitor). For qPCR analysis, 700 μl of Qiazol lysis reagent (Qiagen) was added and samples were vortexed. Finally, miRNA extraction was performed according to the manufacturer's instructions of the kit miRneasy (Qiagen, Hilden, Germany).
miRNA extraction and qPCR
RT and qPCR for miR-30d and miR-450 (used in this experiment to test unspecific binding) were performed with miScript reverse transcription and miScript SYBR Green PCR kits (Qiagen, Hilden, Germany), respectively. In order to quantify the miRNA levels recovered from the immunoprecipitation (Ip), standard curves were done for each miRNA. To do that, mimics for the miR-30d (Ref: MSY0000245, Qiagen, Hilden, Germany) and the miR-450 (Ref: MSY0001545, Qiagen, Hilden, Germany) were retro-transcribed and the following concentrations to construct the curve were used: 0, 5, 15, 20, 25, 50 and 75 pM. The primers used to conduct the qPCR are detailed next: Primer miR-450a-5p: 5′-UUUUGCGAUGU GUUCCUAAUAU; Primer miR-30d: 5′-UGUAAACAUCCCCGACUGG AAG.
Silencing of hnRNPC1 in the Ishikawa cell line
Ishikawa cells were grown in 24-well plates until reaching 70% of confluence, Silencing was performed using Smart Pool Accell HNRNPC siRNA (Dharmacon, Lafayette, CO, USA). This pool consists of several siRNA sequences intended to target different regions of the RNA. Invitrogen™ BLOCK-iT™ Alexa Fluor™ Red Fluorescent Control (Invitrogen, Carlsbad, CA, USA) was used to test the efficiency of the transfection. The Accell non-targeting control siRNA (Dharmacon, Lafayette, CO, USA) was used as a negative control. A time course experiment (24 h, 48 h, 72 h, 90 h and 96 h) was designed to determine the time yielding a maximum reduction in protein. Transfections were performed using Lipofectamine™ (Thermo Fisher Scientific, Waltham, MA, USA), following the manufacturer's instructions. The final concentration of siRNAs in the cell culture was 50 nM. At all analyzed time points, cells were recovered for both RNA and protein extraction. Spent media was also collected to isolate exosomes for detecting packaged miR-30d. For protein and RNA extraction, cells were trypsinized for 5 min, centrifuged at 300g for 5 min and washed twice with PBS before extraction. RNA extraction was done using the RNeasy Kit (Qiagen, Hilden, Germany) and quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific Inc., MA, USA). Protein isolation was carried out by using RIPA buffer as previously described. Western blotting for hnRNPC1 (ab10294, Abcam, Cambridge, UK) was performed as previously described. Actin (ab8227, Abcam, Cambridge, UK) was used as a housekeeping control. Experiments were performed in triplicate.
RT-qPCR
RT-qPCR was performed to determine the messenger levels of hnRNPC1 in cells and miR-30d in both, cells and exosomes. RT and qPCR for miR30d were performed with miScript reverse transcription and miScript SYBR Green PCR kits (Qiagen, Hilden, Germany), respectively. For the determination of the relative quantity of hnRNPC1, the PrimeScript™ RT reagent Kit -Perfect Real Time-(Clontech Laboratories, Mountain View, CA, USA) and LightCycler FastStart DNA Master SYBR (Roche, Basel, Switzerland) were used. Fold changes were estimated using the −2 Co-culture of murine embryos with siRNA hnRNPC1-transfected cells Ishikawa endometrial carcinoma cells were seeded at a density of 80 000 cell/cm 2 in μ-Slide 8-Well ibiTreat plates (Ibidi Gmbh, Planegg/ Martinsried, Germany). At 70% confluency, cells were transfected simultaneously with Smart Pool Accell HNRNPC siRNA (Dharmacon, Lafayette, CO, USA) and the MB probe for detecting miR-30d. After 90 h of transfection, cells were washed with PBS and refreshed with new media. WT and KO blastocysts were transferred onto and allowed to contact the cells for 24 h at 37°C under 5% CO 2 in air. Then, the co-culture was incubated at 37°C for 30 min with 5 μg/ml Hoechst 33342 (Sigma-Aldrich, Madrid, Spain) and 10 μg/ml of WGA-Alexa 488 (Life Technologies, Molecular Probes, Eugene, OR, USA), for nuclear and the membrane staining, respectively. Once labeling was complete, co-cultures were visualized at 60× with a water immersion confocal microscope (FV1000, Olympus). 3D modeling was carried out using Imaris software. Quantification of intensity fluorescence was performed with ImageJ software. Experiments were performed in duplicate, so that in each replicate, the signal distribution of 3-4 embryos, per condition tested, was analyzed.
In the results, a representative experiment is shown.
Embryo adhesion assay
Ishikawa cells transfected with Block-It or sihnRNPC1 and untransfected controls were cultured until confluence in μ-Slide 8-Well ibiTreat plates (Ibidi Gmbh, Planegg/Martinsried, Germany). Then, WT or miR-30d KO embryos were added (14 embryos per condition, six conditions) in two independent experiments (n = 168, total embryos). The attachment of mouse blastocysts to the epithelial cell monolayer was measured after 24 h by mechanical assay. Briefly, plates were moved on a rotation shaker for 10 s, and floating blastocysts were deemed to be unattached.
Statistical analysis
The Statgraphics Centurion software package (v.16.1.11) was used to study the significance of the results. One-way ANOVA was applied with a P-value < 0.05 indicating significance.
Results
Transfer of hsa-miR-30d from human endometrial epithelial cells to trophectoderm cells of invading and hatching miR-30d KO embryos
Here, we co-cultured WT or miR-30d KO blastocysts on hEECs previously transfected with MB probes customized to specifically recognize hsa-miR-30d within living cells (Fig. 1A) . Prior to doing the assays, MB probes were initially characterized to evaluate their specificity for the miR-30d. (Supplementary Fig. 1 ). As it can be seen by the thermal denaturation profiles, fluorescence of the MB is higher with the miR30d compared to the cases where no target or a mismatch target oligonucleotide are used. Figure 1B displays micrographs of hatching and invading embryos obtained from WT and KO mice. The Cy3 fluorophore appears concentrated in the trophectoderm cells of hatching embryos that remain in direct contact with hEECs. However, in the blastocoel cavity of blastocysts still protected by the zona pellucida, the signal was barely detected. In contrast, in invading embryos, the signal was widely distributed throughout the blastocoel, confirming that an intimate cellto-cell contact was necessary for the miRNA transfer. Orthogonal sections of different z-stacks verified that the signal was located inside cells and not attached to surface membranes (Fig. 1B) . The 3D reconstruction of the embryos shown in the Supplementary videos 1-4 corroborates this fact. Moreover, it is noteworthy that the intensity of the signal identified is significantly decreased in KO embryos regardless of the grade of invasion accomplished (Fig. 1C) .
To further understand the transfer of miR-30d from the maternal endometrium to the trophectoderm cells of embryos, WT or KO embryos were co-cultured with hEECs previously transfected with SmartFlare probes, designed specifically for miR-30d recognition. The main characteristic of these probes is the presence of a gold nanoparticle conjugated with many copies of the same double-stranded oligonucleotide encoding the target sequence. In Fig. 2A , a topographic reconstruction of a KO embryo during the adhesion process is presented showing trophectodermal cells stablishing contact with hEECs. The areas with the miR-30d coupled to gold nanoparticles are highlighted in the frames, showing the presence of this probe in miR-30d KO blastocyst, transferred from hEECs. The particles were widely distributed in the cytoplasm as well as in the perinuclear regions of the blastocyst cells embedded into MVBs. Figure 2B shows a reconstruction of a WT embryo on hEECs. Unlike the KO embryo, the zona pellucida of the WT embryo was intact, explaining why gold nanoparticles could only be detected in the transfected epithelial cells.
Screening for the transporter protein of hsa-miR-30d in exosomes
Having phenotypically characterized the transfer of miR-30d in our murine model, we then wanted to elucidate the molecular mechanism responsible for sorting the miRNA into endometrial exosomes before its incorporation into trophectoderm cells. First, we screened for those proteins present in the endometrium and endometrial exosomes that could exert this role within cells. To achieve this, extracts from hEECs (n = 2) and exosomes isolated by ultracentrifugation (pool of supernatants obtained from four T75 hEEC cultures) were incubated with streptavidin beads coated with several copies of a biotinylated miR-30d. As a negative control, poly-A coated beads were used. Once the pull-down was finished, proteins were identified by mass spectrometry. We performed an initial sieving by discarding the proteins that appeared linked to the poly-A beads as well as the ones belonging to the keratins (KRT) gene family. Next, we selected only the set of proteins identified specifically in exosomes and whose ProtScore was ≥2 or the level of confidence ≥99% (Supplementary  file 7) .
Functional analysis revealed that the proteins detected were mainly associated with transcriptional, post-transcriptional modifications, and embryonic morphogenesis (Supplementary Table I ). To proceed with the study, it was considered interesting to select those proteins whose biological function was related in some way with the intercellular mRNA transport. In accordance with this criterion, the heterogeneous ribonucleoprotein C1 (hnRNPC1) was preselected based on a previous report showing its role in the transport of mRNA from the nucleus to the cytosol (Pettit Kneller et al., 2009) . In addition, Cysteine-rich angiogenic inducer 61 (CYR61), a predominantly detected protein in every condition tested was also used for further studies as an unspecific miR-30d binding protein (see Supplementary file 7).
The presence of both proteins in endometrial exosomal fraction was confirmed by western blot analysis (n = 3) (Fig. 3A) . Supernatant obtained in the ultracentrifugation process was used as the negative control. In addition, a western blot of subcellular fractions was performed and detected the enrichment of hnRNPC1 in the protein fraction associated with membranous organelles (Fig. 3B) . CYR61 was detected in the membranous fraction, but its location was predominantly cytoplasmic (Fig. 3B) . We used confocal microscopy to examine co-localization of these proteins with an exosomal marker (CD63) (Fig. 4A) confirming the western blot results. Since, the analyzed subcellular structures are close to the resolution limit of the microscope, we decided to identify the regions of interest (ROI) manually and subsequently measure their fluorescence intensity curves (Bolte and Cordelières, 2006) . To achieve this, we drew vectors through these structures and plotted the fluorescence intensity for the green and red channels against the length of the vector (Fig. 4A) . In the left panel, the results for CYR61 are shown. In this particular example, the exosome marker CD63 appears in green whereas CYR61 is in red. Noticeably, there is no coincidence of the fluorescence intensity distributions for the indicated randomly selected ROI. These results suggest that CYR61 and exosomes do not co-localize, supporting the previous observation that this is not an exosomal protein, so it is unlikely that CYR61could be involved in miR-30d loading into exosomes.
The right panel of Fig. 4A displays the results for hnRNPC1 and CD63 co-localization, this time with hnRNPC1 in green and the exosomal marker CD63 in red. It is important to note that hnRNPC1 was predominantly nuclear, but there is also considerable cytoplasmic staining. Unlike the CYR61 distribution, the hnRNPC1 fluorescence intensity distribution overlapped with CD63 for certain regions of the traced vectors in the cytoplasmatic compartment. This phenomenon suggests a partial co-localization between hnRNPC1 and the exosomes. To eliminate the possibility that this protein might adhere to the membranes of exosomes, a fluorescence-activated cell sorting (FACS) analysis was performed (Fig. 4B) , suggesting that hnRNPC1 fluorescence was higher in permeabilized compared to nonpermeabilized exosomes (Fig. 4B) . This suggests hnRNPC1 could be located inside exosomal structures. Since hnRNPC1 has been described to be predominantly nuclear (Dreyfuss et al., 1993) , we investigated whether this protein could be found in the cytoplasm of cells in a conventional hEEC culture. To achieve this, we compared the protein's fluorescence distribution signal between the nucleus and the cytoplasm with an In-Cell Analyzer (Fig. 4C) . The percentage of signal found in the cytoplasm was higher than the percentage from the nucleus. Feasibly, this sharp difference could be attributed to the surface area analyzed; however, these results seem to confirm the presence of this protein in the cytoplasm of hEECs. This also accords with the study by Kim et al. (2003) that found this protein has the ability to migrate to the cytoplasm depending on the phase of the cell cycle (Kim et al., 2003) .
Finally, specific binding of hnRNPC1 to miR-30d was verified with Ip of hnRNPC1 from exosome lysates followed by qPCR of miRNAs ( Supplementary Fig. 2 ). MiR-30d, but not miR-450, was amplified from hnRNPC1 immunoprecipitates, demonstrating specific binding of hnRNPC1 and miR-30d in exosomes in vitro. Therefore, from the results obtained and given that hnRNPC1 has already been identified as a possible miRNA transporter (Villarroya-Beltri et al., 2013) , it is feasible the existence of an interaction between the protein hnRNPC1 and the miRNA miR-30d prior to its loading into the inner cavity of the exosomes.
Silencing of hnRNPC1 in Ishikawa cells affects the hsa-miR-30d levels within endometrial exosomes
To investigate the possible function of hnRNPC1 in the packaging of miR-30d into exosomes, we assessed the effect of silencing hnRNPC1 in Ishikawa cells. Due to the low survival rate of primary hEECs to transfection, the Ishikawa cell line was selected for silencing of hnRNPC1. This endometrial cancer cell line has provided a good model to study normal endometrium due to its capacity to maintain normal hormonal responsiveness to ovarian steroids (Nishida, 2002) .
Initially, we performed a time course experiment to identify the moment of maximum silencing efficiency (Fig. 5A) . The greatest degree of messenger silencing was achieved 72 h post-transfection (Fig. 5A ). This is in accordance with the results obtained by western blotting, Figure 3 Screening for proteins directing the loading of miR-30d within exosomes. (A) Western blot analysis of CYR61 and hnRNPC1 in human endometrial epithelial cell (hEEC) lysate and exosomes. CD63, CD9, HSP70 and actin were used as exosomal markers. (B) Western blot of the subcellular fractionation performed to test for enrichment of the main candidate protein in the membrane organelle fraction. HSP70 and CD63 were used as cytosol and membrane markers; CD9, CD81 and Calnexin (CNX) were markers for the membrane organelle fraction, His4 was used as a reference for the nuclear fraction, and actin as a marker for the cytoskeletal fraction. somes. In the left panel, staining for CYR61 (red) and the exosome marker CD63 (green) can be observed. The lack of coincidence between the fluorescence intensity distributions for the defined ROI indicates that CYR61 was not present inside exosomes. In the right panel, the co-localization assay for hnRNPC1 (green) and the exosome marker CD63 (red) is shown. The overlap between the fluorescence intensity distributions suggests hnRNPC1 is a possible candidate for loading miR-30d into exosomes. (B) FACS analysis of hnRNPC1 and CD9 in exosome-coupled beads. Exosomes were coupled to aldehyde-sulfate beads, permeabilized or left intact, and incubated with antibodies to hnRNPC1 (lower panels) or CD9 (upper panels) and secondary antibody. Exosomecoupled beads incubated just with secondary antibodies were used as negative controls (left panels). where the lowest yield of protein was obtained 72-96 h posttransfection (Fig. 5B) .
After 90 h of hnRNPC1 knock-down, there was a reduced level of miR-30d in the cellular cytoplasm (P = 0.0001) (n = 3) (Fig. 5C ) as well as in the inner exosomal cavity (P = 0.0152) (n = 3) (Fig. 5D) . WT or mirR-30d KO embryos were co-cultured with Ishikawa cells doublytransfected with the hnRNPC1 siRNA and the MB probe intended for the detection of miR-30d in living cells (n = 2) (Fig. 5E) . Images obtained by confocal microscopy showed that, following hnRNPC1 silencing, there is a reduction of miR-30d transfer between epitheliallike cells and trophectoderm cells (Fig. 5E) . In fact, subsequent image analysis indicates a considerable decrease of the transferred signal, and hence of the miR-30d, in those co-cultures where hnRNPC1 was silenced (Fig. 5F) .
Finally, to determine if a reduction in hnRNPC1 and miR-30d levels may impair blastocyst adhesion to hEEC, in vitro embryo adhesion assays were performed (Fig. 5G) . Specifically, WT or miR-30d KO embryos were added to a monolayer of Ishikawa cells, previously transfected with either sihnRNPC1 or the negative control (Block-It). Adhesion assays show that in non-transfected cells (C-), the adhesion rates on KO embryos are significantly lower than WT (WT: 78.75 ± 2.50% (±SD) versus KO: 60 ± 0.00% (±SD); P = 0.0000) (n = 2; 14 embryos transferred per condition, six conditions tested. Total embryos used: 168). Likewise, transient silencing of hnRNPC1 results in a significant decrease of blastocyst adhesion compared to mock transfection conditions using Block-it, in both WT [66.67 ± 10.01% versus 38.33 ± 8.45% (P = 0.0006)] and miR-30d KO embryos [50.00 ± 11.50% versus 25.50 ± 8.76% (P = 0.0029)]. These results confirm that the highest decrease in the adhesion levels of KO embryos is due to the combined effect of the intrinsic reduction of the endogenous levels of miR-30d and the diminution linked with the drop in hnRNPC1 levels.
Discussion
This study focused on elucidating the possible molecular machinery responsible for the transfer of miR-30d into exosomes during the first stages of maternal-fetal communication. First, we examined the phenotypic characteristics of mouse embryos with a constitutive knock-down of mir-30d. In vitro adhesion assays with hEECs, previously transfected with MB and SmartFlare probes validated our previous results showing that an intimate cell-to-cell contact is necessary for the transfer of miRNAs between cells. This is in accordance with the work of Mittelbrunn et al. (2011) , who determined that exosomes could be transferred between immune cells at a distance, but the formation of an immunological synapse is necessary to enhance the exosomal transition (Mittelbrunn et al., 2011) . miRNA pull-down assay was used to determine which protein could be responsible for the internalization of miR-30d in epithelial-derived exosomes. Results derived from MS/MS revealed the presence of proteins involved in several biological processes including transcriptional changes, post-transcriptional modifications or embryonic morphogenesis. Among the proteins detected, hnRNPC1 seems the most plausible to exert a transport role since both co-localization and FACS analyses demonstrated the presence of this protein in the inner cavity of exosomes.
hnRNPC1 has multiple functions within the eukaryotic cell. It is involved in splicing (Dreyfuss et al., 1993) , stabilization, transport and biogenesis of mRNA (Rajagopalan et al., 1998; Shetty, 2005) and in internal ribosome entry site (IRES)-dependent translation of proteins implicated in cell division and apoptosis (Holcík et al., 2003; Kim et al., 2003) . It performs these functions as stable heterotetramers (Dreyfuss et al., 1993; McAfee et al., 1996) comprised of three molecules of the more abundant hnRNPC1 and one molecule of a slightly larger splice variant, hnRNPC2, which contains a 13-aa insertion (Burd et al., 1989) . Both hnRNPC isoforms contain a basic leucine zipper-like RNA-binding motif, but the functional difference between the two variants remains unclear (McAfee et al., 1996) . Normally, hnRNPC1/C2 resides mainly in the nucleus (Lee et al., 2004) , but certain cellular conditions (e.g. apoptosis, mitosis and viral infection) induce hnRNPC1/ C2 to translocate from the nucleus to the cytoplasm (Nakielny and Dreyfuss, 1996; Sarnow, 2001, 2002; Kim et al., 2003; Lee et al., 2004; Pettit Kneller et al., 2009) . In fact, the results obtained from the In-Cell analyses allowed us to determine that in hEECs the greater proportion of hnRNPC1 in our conditions is cytoplasmic.
The evidence that hnRNPC1 is a plausible transporter of miR-30d into exosomes comes from our silencing assays where a clear decrease in the levels of miR-30d was found in both Ishikawa cells and epithelial-derived exosomes. This sharp reduction of miR-30d inside cells could be associated with a deficiency in the miRNA biogenesis machinery. The ribonucleoprotein family plays pivotal roles in miRNA function by regulating their biogenesis, localization, and degradation (van Kouwenhove et al., 2011) . The KH-type splicing regulatory protein (KSRP) promotes the biogenesis of a subset of miRNAs containing a GGG triplet motif in their terminal loop by enhancing Droshamediated microprocessing. More specifically, phosphorylation of KSRP increases the accessibility of pre-miRNAs thus promoting miRNA biogenesis (Trabucchi et al., 2009) . Similarly, hnRNPA1 binds to a conserved loop region of miRNAs facilitating Drosha-mediated cleavage (Michlewski et al., 2008) . Although more exhaustive research is needed to determine the exact way in which hnRNPC1 interacts with miR-30d, it seems that its biological role in RNA splicing and mRNA stability could be compromising both miR-30d biogenesis and its subsequent transfer. A similar conclusion was obtained by Park et al. (2012) who described that the silencing of hnRNPC1 was closely related with reduced levels of miR-21 in glioblastoma cells (Park et al., 2012) .
negative control (Block-It) and sihnRNPC1. Showed adhesion rates are significantly lower in case of using KO embryos (WT: 78.75 ± 2.50% versus KO: 60 ± 0.00%; P < 0.0001) in baseline conditions. In both cases, there exists a significant decrease in the adhesion percentages after conducting the transient silencing of hnRNPC1. This decrease is relevant in the comparison established with baseline conditions [WT: 78.75 ± 2.50% versus 38.33 ± 8.45% (P < 0.0001); KO: 60 ± 0.0% versus 25.50 ± 8.76% (P < 0.0001)], as in the case of carrying out a transfection with the negative control Block-it [WT: 66.67 ± 10.01% versus 38.33 ± 8.45% (P = 0.0006); KO: 50 ± 11.5% versus 25.5 ± 8.76% (P = 0.0029)]. Results are presented in the format mean ± SD (n = 2; 14 embryos transfer per condition, six conditions tested; Total embryos transferred n = 168).
Finally, proof-of-concept evidence for the possible role of hnRNPC1 in miR-30d transfer comes from the co-culture of WT or miR-30d KO embryos with sihnRNPC1 cells. Knocking down hnRNPC1 compromises the detection of the miR-30d-CY3 signal throughout the embryo structure in two of the main stages of implantation: adhesion and invasion. Regardless the embryo was WT or KO, the levels of miR-30d were significantly reduced. In turn, adhesion assays showed that the transient silencing of hnRNPC1 resulted in a significant decrease of the adhesion rates in both genotypes, being this reduction more pronounced in miR-30d KO embryos. This negative effect at the beginning of embryo implantation could be associated to an additive effect derived from a simultaneous absence of the miRNA miR-30d and the protein hnRNPC1.
It is important to note that although the experiments were done in cells derived from human adenocarcinomas (Ishikawa cells), they are likely to be relevant for human embryo implantation since Ishikawa cells have been the most useful models for examining the early events and interactions that occur between the endometrium and the trophectoderm (Hannan et al., 2009) . In fact, Zhang et al. (2012) developed a similar model of embryo implantation using mouse blastocysts and Ishikawa cells in which the blastocyst ultimately attached and grew. Scanning electron micrographs and immunocytochemical results of the implantation marker Leukemia Inhibitory Factor (LIF), confirmed the viability, biochemical integrity and responsiveness to implantation events of the Ishikawa cell line. Therefore, given these results, we consider that hnRNPC1 could exert a relevant role in the maternal-fetal communication by participating both, in the biogenesis of miR-30d and its subsequent transport to trophectoderm cells.
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